- Home
- GP vs AFMD Comparison
GP vs AFMD Comparison
Compare GP & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- AFMD
- Stock Information
- Founded
- GP 2010
- AFMD 2000
- Country
- GP Canada
- AFMD Germany
- Employees
- GP N/A
- AFMD N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- AFMD Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- AFMD Health Care
- Exchange
- GP Nasdaq
- AFMD Nasdaq
- Market Cap
- GP 16.2M
- AFMD 14.5M
- IPO Year
- GP 2020
- AFMD 2014
- Fundamental
- Price
- GP $0.46
- AFMD $0.64
- Analyst Decision
- GP Strong Buy
- AFMD Strong Buy
- Analyst Count
- GP 2
- AFMD 5
- Target Price
- GP $2.33
- AFMD $13.50
- AVG Volume (30 Days)
- GP 78.5K
- AFMD 87.4K
- Earning Date
- GP 02-14-2025
- AFMD 04-08-2025
- Dividend Yield
- GP N/A
- AFMD N/A
- EPS Growth
- GP N/A
- AFMD N/A
- EPS
- GP N/A
- AFMD N/A
- Revenue
- GP $20,656,035.00
- AFMD $6,287,085.00
- Revenue This Year
- GP N/A
- AFMD N/A
- Revenue Next Year
- GP $94.25
- AFMD $225.65
- P/E Ratio
- GP N/A
- AFMD N/A
- Revenue Growth
- GP N/A
- AFMD N/A
- 52 Week Low
- GP $0.41
- AFMD $0.69
- 52 Week High
- GP $1.91
- AFMD $8.95
- Technical
- Relative Strength Index (RSI)
- GP 36.46
- AFMD 18.63
- Support Level
- GP $0.41
- AFMD $0.85
- Resistance Level
- GP $0.51
- AFMD $0.79
- Average True Range (ATR)
- GP 0.05
- AFMD 0.06
- MACD
- GP -0.00
- AFMD -0.01
- Stochastic Oscillator
- GP 26.75
- AFMD 0.00
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About AFMD Affimed N.V.
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.